Judy Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Judy Li has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
Cassius Iyad Ochoa Chaar
4 shared publications- Zyad James Carr
Department of Anesthesiology, Yale University School of Medicine, TMP-3, 333 Cedar Street, New Haven, CT 06520, USA
3 shared publications - Andres Brenes-Bastos
Yale University, School of Medicine, Department of Anesthesiology, 333 Cedar StreetTMP-3, New Haven, US
2 shared publications Britt H. Tonnessen
Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale School of Medicine, New Haven, CT
2 shared publications- Daniel Agarkov
Yale University, School of Medicine, Department of Anesthesiology, 333 Cedar StreetTMP-3, New Haven, US
2 shared publications David P. Kuwayama
Division of Vascular Surgery and Endovascular Therapy, Department of Surgery, Yale School of Medicine, New Haven, CT
2 shared publications
Latest Publications
- 28 October 2026
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 135, 230-241
Antiplatelet Therapy and Bleeding, Cardiovascular Events, and Aneurysm Growth in Patients with Abdominal Aortic Aneurysms
- 28 October 2026
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 135, 230-241
Antiplatelet Therapy and Bleeding, Cardiovascular Events, and Aneurysm Growth in Patients with Abdominal Aortic Aneurysms
- 11 May 2026
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (7)
Trajectories of cognitive performance in the six months after hospitalization with COVID-19 among community-dwelling older adults
Background: Older adults are vulnerable to post-COVID-19 cognitive impairment (CI). This study aimed to characterize cognitive trajectories among older adults in the 6 months after hospitalization with COVID-19 and identify associated factors. Methods: This prospective longitudinal cohort study included 311 community-dwelling adults age ≥60 years hospitalized with COVID-19 and enrolled in the VALIANT (COVID-19 in Older Adults: A Longitudinal Assessment) study between June 2020 and June 2021. Cognitive performance was assessed using the Montreal Cognitive Assessment 5-min protocol during hospitalization and at 1, 3, and 6 months post-discharge. Sociodemographic and clinical data were collected via baseline interviews and the electronic health record. Cognitive trajectories and their associated factors were identified using discrete mixture models and multinomial logistic regression. Results: Mean age was 71.4 ± 8.4 years (54.6% women, 3.7% with documented evidence of pre-admission CI, 41% with in-hospital CI). Three cognitive trajectories were identified at 6 months post-discharge: persistent moderate impairment (14.1%), borderline impairment (47.5%), and no impairment (38.4%). Factors associated with membership in persistent moderate or borderline impairment trajectories, relative to the no impairment trajectory, were in-hospital cognitive performance, delirium, hearing impairment, and multimorbidity. Pre-admission CI perfectly predicted membership in the no impairment trajectory (ie, zero participants in the no impairment trajectory had pre-admission CI). Conclusions: Distinct cognitive trajectories of persistent moderate impairment, borderline impairment, and no impairment emerged among older adults during the 6 months after hospitalization for COVID-19. Trajectory membership was predicted by several clinical factors, screening for which may be useful in predicting cognitive trajectories after COVID-19 hospitalization.
- 11 May 2026
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (7)
Trajectories of cognitive performance in the six months after hospitalization with COVID-19 among community-dwelling older adults
Background: Older adults are vulnerable to post-COVID-19 cognitive impairment (CI). This study aimed to characterize cognitive trajectories among older adults in the 6 months after hospitalization with COVID-19 and identify associated factors. Methods: This prospective longitudinal cohort study included 311 community-dwelling adults age ≥60 years hospitalized with COVID-19 and enrolled in the VALIANT (COVID-19 in Older Adults: A Longitudinal Assessment) study between June 2020 and June 2021. Cognitive performance was assessed using the Montreal Cognitive Assessment 5-min protocol during hospitalization and at 1, 3, and 6 months post-discharge. Sociodemographic and clinical data were collected via baseline interviews and the electronic health record. Cognitive trajectories and their associated factors were identified using discrete mixture models and multinomial logistic regression. Results: Mean age was 71.4 ± 8.4 years (54.6% women, 3.7% with documented evidence of pre-admission CI, 41% with in-hospital CI). Three cognitive trajectories were identified at 6 months post-discharge: persistent moderate impairment (14.1%), borderline impairment (47.5%), and no impairment (38.4%). Factors associated with membership in persistent moderate or borderline impairment trajectories, relative to the no impairment trajectory, were in-hospital cognitive performance, delirium, hearing impairment, and multimorbidity. Pre-admission CI perfectly predicted membership in the no impairment trajectory (ie, zero participants in the no impairment trajectory had pre-admission CI). Conclusions: Distinct cognitive trajectories of persistent moderate impairment, borderline impairment, and no impairment emerged among older adults during the 6 months after hospitalization for COVID-19. Trajectory membership was predicted by several clinical factors, screening for which may be useful in predicting cognitive trajectories after COVID-19 hospitalization.
- 2 April 2026
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 129, 265-274
Risk Factors for Delirium after Abdominal Aortic Aneurysm Repair
- 2 April 2026
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 129, 265-274
Risk Factors for Delirium after Abdominal Aortic Aneurysm Repair
- 20 March 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (1) , 219-228.e2
Frailty is associated with increased risk for upper arm arteriovenous fistula abandonment
- 20 March 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (1) , 219-228.e2
Frailty is associated with increased risk for upper arm arteriovenous fistula abandonment
- 18 August 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (1) , 79-90.e2
Frailty and functional decline after elective endovascular abdominal aortic aneurysm repair in octogenarians
- 18 August 2025
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (1) , 79-90.e2
Frailty and functional decline after elective endovascular abdominal aortic aneurysm repair in octogenarians
- Open Access
- 17 February 2025
- Published by JMIR Publications Inc. in JMIR Perioperative Medicine
- Vol. 8, e65805
Implementation of Brief Submaximal Cardiopulmonary Testing in a High-Volume Presurgical Evaluation Clinic: Feasibility Cohort Study
Background: Precise functional capacity assessment is a critical component for preoperative risk stratification. Brief submaximal cardiopulmonary exercise testing (smCPET) has shown diagnostic utility in various cardiopulmonary conditions. Objective: This study aims to determine if smCPET could be implemented in a high-volume presurgical evaluation clinic and, when compared to structured functional capacity surveys, if smCPET could better discriminate low functional capacity (≤4.6 metabolic equivalents [METs]). Methods: After institutional approval, 43 participants presenting for noncardiac surgery who met the following inclusion criteria were enrolled: aged 60 years and older, a Revised Cardiac Risk Index of ≤2, and self-reported METs of ≥4.6 (self-endorsed ability to climb 2 flights of stairs). Subjective METs assessments, Duke Activity Status Index (DASI) surveys, and a 6-minute smCPET trial were conducted. The primary end points were (1) operational efficiency, based on the time of the experimental session being ≤20 minutes; (2) modified Borg survey of perceived exertion, with a score of ≤7 indicating no more than moderate exertion; (3) high participant satisfaction with smCPET task execution, represented as a score of ≥8 (out of 10); and (4) high participant satisfaction with smCPET scheduling, represented as a score of ≥8 (out of 10). Student's t test was used to determine the significance of the secondary end points. Correlation between comparable structured surveys and smCPET measurements was assessed using the Pearson correlation coefficient. A Bland-Altman analysis was used to assess agreement between the methods. Results: The mean session time was 16.9 (SD 6.8) minutes. The mean posttest modified Borg survey score was 5.35 (SD 1.8). The median patient satisfaction (on a scale of 1=worst to 10=best) was 10 (IQR 10-10) for scheduling and 10 (IQR 9-10) for task execution. Subjective METs were higher when compared to smCPET equivalents (extrapolated peak METs; mean 7.6, SD 2.0 vs mean 6.7, SD 1.8; t42=2.1; P<.001). DASI-estimated peak METs were higher when compared to smCPET peak METs (mean 8.8, SD 1.2 vs mean 6.7, SD 1.8; t42=7.2; P<.001). DASI-estimated peak oxygen uptake was higher than smCPET peak oxygen uptake (mean 30.9, SD 4.3 mL kg–1 min–1 vs mean 23.6, SD 6.5 mL kg–1 min–1; t42=7.2; P<.001). Conclusions: Implementation of smCPET in a presurgical evaluation clinic is both patient centered and clinically feasible. Brief smCPET measures, supportive of published reports regarding low sensitivity of provider-driven or structured survey measures for low functional capacity, were lower than those from structured surveys. Future studies will analyze the prediction of perioperative complications and cost-effectiveness. Trial Registration: ClinicalTrials.gov NCT05743673; https://clinicaltrials.gov/study/NCT05743673
- 17 February 2025
- Published by JMIR Publications Inc. in JMIR Perioperative Medicine
- Vol. 8, e65805
Open AccessImplementation of Brief Submaximal Cardiopulmonary Testing in a High-Volume Presurgical Evaluation Clinic: Feasibility Cohort Study
Background: Precise functional capacity assessment is a critical component for preoperative risk stratification. Brief submaximal cardiopulmonary exercise testing (smCPET) has shown diagnostic utility in various cardiopulmonary conditions. Objective: This study aims to determine if smCPET could be implemented in a high-volume presurgical evaluation clinic and, when compared to structured functional capacity surveys, if smCPET could better discriminate low functional capacity (≤4.6 metabolic equivalents [METs]). Methods: After institutional approval, 43 participants presenting for noncardiac surgery who met the following inclusion criteria were enrolled: aged 60 years and older, a Revised Cardiac Risk Index of ≤2, and self-reported METs of ≥4.6 (self-endorsed ability to climb 2 flights of stairs). Subjective METs assessments, Duke Activity Status Index (DASI) surveys, and a 6-minute smCPET trial were conducted. The primary end points were (1) operational efficiency, based on the time of the experimental session being ≤20 minutes; (2) modified Borg survey of perceived exertion, with a score of ≤7 indicating no more than moderate exertion; (3) high participant satisfaction with smCPET task execution, represented as a score of ≥8 (out of 10); and (4) high participant satisfaction with smCPET scheduling, represented as a score of ≥8 (out of 10). Student's t test was used to determine the significance of the secondary end points. Correlation between comparable structured surveys and smCPET measurements was assessed using the Pearson correlation coefficient. A Bland-Altman analysis was used to assess agreement between the methods. Results: The mean session time was 16.9 (SD 6.8) minutes. The mean posttest modified Borg survey score was 5.35 (SD 1.8). The median patient satisfaction (on a scale of 1=worst to 10=best) was 10 (IQR 10-10) for scheduling and 10 (IQR 9-10) for task execution. Subjective METs were higher when compared to smCPET equivalents (extrapolated peak METs; mean 7.6, SD 2.0 vs mean 6.7, SD 1.8; t42=2.1; P<.001). DASI-estimated peak METs were higher when compared to smCPET peak METs (mean 8.8, SD 1.2 vs mean 6.7, SD 1.8; t42=7.2; P<.001). DASI-estimated peak oxygen uptake was higher than smCPET peak oxygen uptake (mean 30.9, SD 4.3 mL kg–1 min–1 vs mean 23.6, SD 6.5 mL kg–1 min–1; t42=7.2; P<.001). Conclusions: Implementation of smCPET in a presurgical evaluation clinic is both patient centered and clinically feasible. Brief smCPET measures, supportive of published reports regarding low sensitivity of provider-driven or structured survey measures for low functional capacity, were lower than those from structured surveys. Future studies will analyze the prediction of perioperative complications and cost-effectiveness. Trial Registration: ClinicalTrials.gov NCT05743673; https://clinicaltrials.gov/study/NCT05743673
- Open Access
- 26 August 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Implementation of Brief Submaximal Cardiopulmonary Testing in a High-Volume Presurgical Evaluation Clinic: Feasibility Cohort Study (Preprint)
BACKGROUND Precise functional capacity assessment is a critical component for preoperative risk stratification. Brief submaximal cardiopulmonary exercise testing (smCPET) has shown diagnostic utility in various cardiopulmonary conditions. OBJECTIVE This study aims to determine if smCPET could be implemented in a high-volume presurgical evaluation clinic and, when compared to structured functional capacity surveys, if smCPET could better discriminate low functional capacity (≤4.6 metabolic equivalents [METs]). METHODS After institutional approval, 43 participants presenting for noncardiac surgery who met the following inclusion criteria were enrolled: aged 60 years and older, a Revised Cardiac Risk Index of ≤2, and self-reported METs of ≥4.6 (self-endorsed ability to climb 2 flights of stairs). Subjective METs assessments, Duke Activity Status Index (DASI) surveys, and a 6-minute smCPET trial were conducted. The primary end points were (1) operational efficiency, based on the time of the experimental session being ≤20 minutes; (2) modified Borg survey of perceived exertion, with a score of ≤7 indicating no more than moderate exertion; (3) high participant satisfaction with smCPET task execution, represented as a score of ≥8 (out of 10); and (4) high participant satisfaction with smCPET scheduling, represented as a score of ≥8 (out of 10). Student's t test was used to determine the significance of the secondary end points. Correlation between comparable structured surveys and smCPET measurements was assessed using the Pearson correlation coefficient. A Bland-Altman analysis was used to assess agreement between the methods. RESULTS The mean session time was 16.9 (SD 6.8) minutes. The mean posttest modified Borg survey score was 5.35 (SD 1.8). The median patient satisfaction (on a scale of 1=worst to 10=best) was 10 (IQR 10-10) for scheduling and 10 (IQR 9-10) for task execution. Subjective METs were higher when compared to smCPET equivalents (extrapolated peak METs; mean 7.6, SD 2.0 vs mean 6.7, SD 1.8; t42=2.1; P<.001). DASI-estimated peak METs were higher when compared to smCPET peak METs (mean 8.8, SD 1.2 vs mean 6.7, SD 1.8; t42=7.2; P<.001). DASI-estimated peak oxygen uptake was higher than smCPET peak oxygen uptake (mean 30.9, SD 4.3 mL kg–1 min–1 vs mean 23.6, SD 6.5 mL kg–1 min–1; t42=7.2; P<.001). CONCLUSIONS Implementation of smCPET in a presurgical evaluation clinic is both patient centered and clinically feasible. Brief smCPET measures, supportive of published reports regarding low sensitivity of provider-driven or structured survey measures for low functional capacity, were lower than those from structured surveys. Future studies will analyze the prediction of perioperative complications and cost-effectiveness. CLINICALTRIAL ClinicalTrials.gov NCT05743673; https://clinicaltrials.gov/study/NCT05743673
- 26 August 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessImplementation of Brief Submaximal Cardiopulmonary Testing in a High-Volume Presurgical Evaluation Clinic: Feasibility Cohort Study (Preprint)
BACKGROUND Precise functional capacity assessment is a critical component for preoperative risk stratification. Brief submaximal cardiopulmonary exercise testing (smCPET) has shown diagnostic utility in various cardiopulmonary conditions. OBJECTIVE This study aims to determine if smCPET could be implemented in a high-volume presurgical evaluation clinic and, when compared to structured functional capacity surveys, if smCPET could better discriminate low functional capacity (≤4.6 metabolic equivalents [METs]). METHODS After institutional approval, 43 participants presenting for noncardiac surgery who met the following inclusion criteria were enrolled: aged 60 years and older, a Revised Cardiac Risk Index of ≤2, and self-reported METs of ≥4.6 (self-endorsed ability to climb 2 flights of stairs). Subjective METs assessments, Duke Activity Status Index (DASI) surveys, and a 6-minute smCPET trial were conducted. The primary end points were (1) operational efficiency, based on the time of the experimental session being ≤20 minutes; (2) modified Borg survey of perceived exertion, with a score of ≤7 indicating no more than moderate exertion; (3) high participant satisfaction with smCPET task execution, represented as a score of ≥8 (out of 10); and (4) high participant satisfaction with smCPET scheduling, represented as a score of ≥8 (out of 10). Student's t test was used to determine the significance of the secondary end points. Correlation between comparable structured surveys and smCPET measurements was assessed using the Pearson correlation coefficient. A Bland-Altman analysis was used to assess agreement between the methods. RESULTS The mean session time was 16.9 (SD 6.8) minutes. The mean posttest modified Borg survey score was 5.35 (SD 1.8). The median patient satisfaction (on a scale of 1=worst to 10=best) was 10 (IQR 10-10) for scheduling and 10 (IQR 9-10) for task execution. Subjective METs were higher when compared to smCPET equivalents (extrapolated peak METs; mean 7.6, SD 2.0 vs mean 6.7, SD 1.8; t42=2.1; P<.001). DASI-estimated peak METs were higher when compared to smCPET peak METs (mean 8.8, SD 1.2 vs mean 6.7, SD 1.8; t42=7.2; P<.001). DASI-estimated peak oxygen uptake was higher than smCPET peak oxygen uptake (mean 30.9, SD 4.3 mL kg–1 min–1 vs mean 23.6, SD 6.5 mL kg–1 min–1; t42=7.2; P<.001). CONCLUSIONS Implementation of smCPET in a presurgical evaluation clinic is both patient centered and clinically feasible. Brief smCPET measures, supportive of published reports regarding low sensitivity of provider-driven or structured survey measures for low functional capacity, were lower than those from structured surveys. Future studies will analyze the prediction of perioperative complications and cost-effectiveness. CLINICALTRIAL ClinicalTrials.gov NCT05743673; https://clinicaltrials.gov/study/NCT05743673
- Open Access
- 23 February 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (2) , e0299137
Estimates of 30-day postoperative pulmonary complications after gastrointestinal endoscopic procedures: A retrospective cohort analysis of a health system population
The incidence of 30-day postoperative pulmonary complications (PPC) of gastrointestinal endoscopic procedures (GIEP) are not well characterized in the literature. The primary aim of this study was to identify the incidence of 30-day PPC after GIEP within a large healthcare system. We conducted a retrospective cohort study of 5377 patients presenting for GIEP between January 2013 and January 2022. Our primary outcome was the Agency for Healthcare Research and Quality PPC composite (AHRQ-PPC). Secondary outcomes were sub-composites derived from the AHRQ-PPC; including pneumonia (AHRQ-PNA), respiratory failure (AHRQ-RF), aspiration pneumonia/ pneumonitis (AHRQ-ASP) and pulmonary emboli (AHRQ-PE). We performed propensity score matching (PSM) followed by multivariable logistic regression to analyze primary and secondary outcomes. Inpatients had higher 30-day AHRQ-PPC (6.0 vs. 1.2%, padj: 2.66 95%CI (1.29, 5.49), p = 0.01], congestive heart failure (CHF) [22.3 vs. 8.7%, ORadj: 2.2 95%CI (1.17, 4.15), p = 0.02] and pulmonary circulatory disorders [21 vs. 16.9%, ORadj: 2.95, 95%CI (1.36, 6.39), p = 0.01] were associated with 30-day AHRQ-PPC. After covariate adjustment, AHRQ-PPC was associated with upper endoscopy more than lower endoscopy [5.9 vs. 1.0%, ORadj: 3.76, 95%CI (1.85, 7.66), padj: 0.032, 95%CI (0.01, 0.22), padj: 0.002, 95%CI (0.00, 0.55), p<0.001]. In conclusion, we report estimates of 30-day PPC after GIEP across inpatient and outpatient settings. Upper endoscopic procedures confer a higher risk, while the presence of an anesthesia care team may be protective against 30-day PPC.
- 23 February 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (2) , e0299137
Open AccessEstimates of 30-day postoperative pulmonary complications after gastrointestinal endoscopic procedures: A retrospective cohort analysis of a health system population
The incidence of 30-day postoperative pulmonary complications (PPC) of gastrointestinal endoscopic procedures (GIEP) are not well characterized in the literature. The primary aim of this study was to identify the incidence of 30-day PPC after GIEP within a large healthcare system. We conducted a retrospective cohort study of 5377 patients presenting for GIEP between January 2013 and January 2022. Our primary outcome was the Agency for Healthcare Research and Quality PPC composite (AHRQ-PPC). Secondary outcomes were sub-composites derived from the AHRQ-PPC; including pneumonia (AHRQ-PNA), respiratory failure (AHRQ-RF), aspiration pneumonia/ pneumonitis (AHRQ-ASP) and pulmonary emboli (AHRQ-PE). We performed propensity score matching (PSM) followed by multivariable logistic regression to analyze primary and secondary outcomes. Inpatients had higher 30-day AHRQ-PPC (6.0 vs. 1.2%, padj: 2.66 95%CI (1.29, 5.49), p = 0.01], congestive heart failure (CHF) [22.3 vs. 8.7%, ORadj: 2.2 95%CI (1.17, 4.15), p = 0.02] and pulmonary circulatory disorders [21 vs. 16.9%, ORadj: 2.95, 95%CI (1.36, 6.39), p = 0.01] were associated with 30-day AHRQ-PPC. After covariate adjustment, AHRQ-PPC was associated with upper endoscopy more than lower endoscopy [5.9 vs. 1.0%, ORadj: 3.76, 95%CI (1.85, 7.66), padj: 0.032, 95%CI (0.01, 0.22), padj: 0.002, 95%CI (0.00, 0.55), p<0.001]. In conclusion, we report estimates of 30-day PPC after GIEP across inpatient and outpatient settings. Upper endoscopic procedures confer a higher risk, while the presence of an anesthesia care team may be protective against 30-day PPC.
- Open Access
- 21 December 2023
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 25, e942659-e942659-9
Uncovering Primary Extranodal Diffuse Large B Cell Lymphoma in the Adrenal and Thyroid Glands
BACKGROUND Primary extranodal diffuse large B-cell lymphoma (DLBCL) is a rare, yet highly aggressive and invasive malignancy that can masquerade as a solid organ tumor. Timely diagnosis is critical for improving prognosis; however, it is challenging to achieve. CASE REPORT We report 2 cases treated at Yale New Haven Hospital (New Haven, CT, USA) and the West Haven Veteran's Affairs Medical Center (West Haven, CT, USA) in 2023. Case 1 describes a 69-year-old woman who presented with a large left adrenal mass that was suspicious for adrenocortical carcinoma and was found to have primary adrenal DLBCL following surgical resection. Case 2 describes a 59-year-old woman with Hashimoto's thyroiditis and goiter who was found to have primary thyroid DLBCL following partial thyroidectomy. CONCLUSIONS Primary extranodal DLBCL should be included in the differential diagnosis of solid adrenal and thyroid tumors. The risks of biopsy, given currently available techniques, should be weighed against the benefits of achieving a definite diagnosis, allowing for timely initiation of systemic immunochemotherapy. When biopsy can be safely performed, techniques designed to evaluate for DLBCL should be incorporated.
- 21 December 2023
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 25, e942659-e942659-9
Open AccessUncovering Primary Extranodal Diffuse Large B Cell Lymphoma in the Adrenal and Thyroid Glands
BACKGROUND Primary extranodal diffuse large B-cell lymphoma (DLBCL) is a rare, yet highly aggressive and invasive malignancy that can masquerade as a solid organ tumor. Timely diagnosis is critical for improving prognosis; however, it is challenging to achieve. CASE REPORT We report 2 cases treated at Yale New Haven Hospital (New Haven, CT, USA) and the West Haven Veteran's Affairs Medical Center (West Haven, CT, USA) in 2023. Case 1 describes a 69-year-old woman who presented with a large left adrenal mass that was suspicious for adrenocortical carcinoma and was found to have primary adrenal DLBCL following surgical resection. Case 2 describes a 59-year-old woman with Hashimoto's thyroiditis and goiter who was found to have primary thyroid DLBCL following partial thyroidectomy. CONCLUSIONS Primary extranodal DLBCL should be included in the differential diagnosis of solid adrenal and thyroid tumors. The risks of biopsy, given currently available techniques, should be weighed against the benefits of achieving a definite diagnosis, allowing for timely initiation of systemic immunochemotherapy. When biopsy can be safely performed, techniques designed to evaluate for DLBCL should be incorporated.